Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

NCT07204366 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

219

Enrollment

OTHER

Sponsor class

Conditions

Myeloproliferative Disease
COVID - 19

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia